Cyfuse Biomedical K.K. (4892.T)

JPY 463.0

(2.89%)

Operating Expenses Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual operating expenses in 2023 was 735.18 Million JPY , up 10.29% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly operating expenses in 2024 Q2 was 211.06 Million JPY , down -6.79% from previous quarter.
  • Cyfuse Biomedical K.K. reported a annual operating expenses of 666.58 Million JPY in annual operating expenses 2022, up 33.31% from previous year.
  • Cyfuse Biomedical K.K. reported a annual operating expenses of 500.03 Million JPY in annual operating expenses 2021, up 13.86% from previous year.
  • Cyfuse Biomedical K.K. reported a quarterly operating expenses of 236.16 Million JPY for 2024 Q1, up 21.17% from previous quarter.
  • Cyfuse Biomedical K.K. reported a quarterly operating expenses of 194.89 Million JPY for 2023 Q4, up 16.68% from previous quarter.

Annual Operating Expenses Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Operating Expenses of Cyfuse Biomedical K.K. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 735.18 Million JPY 10.29%
2022 666.58 Million JPY 33.31%
2021 500.03 Million JPY 13.86%
2020 439.15 Million JPY 0.0%

Peer Operating Expenses Comparison of Cyfuse Biomedical K.K.

Name Operating Expenses Operating Expenses Difference
Pharma Foods International Co., Ltd. 43.63 Billion JPY 98.315%
Takeda Pharmaceutical Company Limited 2618.18 Billion JPY 99.972%
Sumitomo Pharma Co., Ltd. 542.17 Billion JPY 99.864%
Shionogi & Co., Ltd. 197.62 Billion JPY 99.628%
Wakamoto Pharmaceutical Co.,Ltd. 3.73 Billion JPY 80.324%
Nippon Shinyaku Co., Ltd. 65.63 Billion JPY 98.88%
Kaken Pharmaceutical Co., Ltd. 29.02 Billion JPY 97.467%
Eisai Co., Ltd. 533.01 Billion JPY 99.862%
Morishita Jintan Co., Ltd. 5.28 Billion JPY 86.081%
Hisamitsu Pharmaceutical Co., Inc. 65.8 Billion JPY 98.883%
Mochida Pharmaceutical Co., Ltd. 46.26 Billion JPY 98.411%
Fuso Pharmaceutical Industries,Ltd. 11.55 Billion JPY 93.636%
Nippon Chemiphar Co., Ltd. 8.23 Billion JPY 91.069%
Tsumura & Co. 48.8 Billion JPY 98.493%
Kissei Pharmaceutical Co., Ltd. 33.32 Billion JPY 97.794%
Torii Pharmaceutical Co., Ltd. 19.53 Billion JPY 96.237%
Towa Pharmaceutical Co., Ltd. 63.73 Billion JPY 98.847%
Fuji Pharma Co., Ltd. 12.65 Billion JPY 94.192%
Zeria Pharmaceutical Co., Ltd. 40.46 Billion JPY 98.183%
KYORIN Holdings, Inc. 45.39 Billion JPY 98.38%
Taiko Pharmaceutical Co.,Ltd. 4.15 Billion JPY 82.315%
Daito Pharmaceutical Co.,Ltd. 5.94 Billion JPY 87.634%
SymBio Pharmaceuticals Limited 5.22 Billion JPY 85.923%
MedRx Co., Ltd 959 Million JPY 23.339%
Mizuho Medy Co.,Ltd. 2.87 Billion JPY 74.417%
Solasia Pharma K.K. 1.47 Billion JPY 50.191%
Modalis Therapeutics Corporation 2.37 Billion JPY 68.988%
ASKA Pharmaceutical Holdings Co.,Ltd. 24.16 Billion JPY 96.958%
Sawai Group Holdings Co., Ltd. 35.43 Billion JPY 97.925%
Toho Holdings Co., Ltd. 99.81 Billion JPY 99.263%
Koa Shoji Holdings Co.,Ltd. 2.25 Billion JPY 67.431%